2025-05-30 - Analysis Report
Okay, here's a report analyzing Intuitive Surgical Inc. (ISRG) based on the provided data.

**Intuitive Surgical Inc. (ISRG) Analysis**

**1. Performance Relative to S&P 500 (VOO)**

*   **Ticker:** ISRG
*   **Company Overview:** Intuitive Surgical designs, manufactures, and markets the da Vinci surgical system and related instruments and accessories.

**Key Metrics:**

*   **ISRG Cumulative Return:** 133.92%
*   **VOO (S&P 500) Cumulative Return:** 82.09%
*   **Absolute Spread:** 51.8
*   **Spread Range (Max: 121.5, Min: -6.7)**
*   **Relative Spread:** 45.6

**Analysis:** ISRG has significantly outperformed the S&P 500 based on cumulative returns. The relative spread indicates that ISRG's outperformance is in the mid-range of its historical outperformance relative to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha  | Beta | Cap(B) |
|------------|--------|--------|--------|------|--------|
| 2015-2017  | 68.0%  | 56.5%  | 38.0%  | 0.0  | 43.6   |
| 2016-2018  | 77.0%  | 63.4%  | 60.0%  | 0.0  | 57.2   |
| 2017-2019  | 81.0%  | 63.4%  | 52.0%  | 0.3  | 70.6   |
| 2018-2020  | 47.0%  | 63.4%  | 22.0%  | 0.2  | 97.7   |
| 2019-2021  | 91.0%  | 63.0%  | 37.0%  | 0.3  | 128.8  |
| 2020-2022  | -3.0%  | 69.9%  | -9.0%  | 0.3  | 95.1   |
| 2021-2023  | -5.0%  | 72.9%  | -22.0% | 1.0  | 120.9  |
| 2022-2024  | 26.0%  | 72.9%  | 9.0%   | 1.0  | 187.1  |
| 2023-2025  | 55.0%  | 72.9%  | 25.0%  | 0.7  | 199.2  |

**Analysis:**

*   **CAGR:** Fluctuates significantly, with periods of high growth followed by declines. Recent years (2020-2023) show weaker performance.
*   **MDD:** High Maximum Drawdown indicates significant volatility and potential risk.
*   **Alpha:** Mixed alpha values suggest periods of outperformance and underperformance relative to the market.
*   **Beta:** Beta values indicate the stock generally moves in the same direction as the market, with sensitivity fluctuating over time.
*   **Cap(B):** Market capitalization has generally increased over time, reflecting growth (but potentially impacting future growth rates).

**2. Recent Price Movement**

*   **Current Price:** 555.75
*   **Last Market Data:** Price: 555.75, Previous Close: 552.41, Change: 0.6
*   **5-Day Moving Average:** 548.11
*   **20-Day Moving Average:** 547.07
*   **60-Day Moving Average:** 513.41

**Analysis:** The stock price is trading above its 5-day, 20-day, and 60-day moving averages, indicating a short-term and intermediate-term upward trend. The recent positive change suggests continued momentum.

**3. Technical Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.37 (Low Risk)
*   **RSI:** 60.95 (Approaching overbought territory)
*   **PPO:** -0.31
*   **Hybrid Signal:** Cash_69%_Sell 0.6% of holdings (1 shares - Caution - MRI:0.37)
*   **Recent (20-Day) Relative Spread Change:** -2.8 (Negative - Short-Term Decline)
*   **Expected Return:** 45.5% (Long-Term, vs. S&P 500)

**Analysis:**

*   The MRI indicates a low-risk environment.
*   The RSI suggests the stock is approaching overbought levels, potentially signaling a future pullback.
*   The negative PPO suggests that the stock may be underperforming the index.
*   The hybrid signal suggests a cautious approach, recommending a slight reduction in holdings.
*   The negative change in relative spread indicates a recent weakening compared to the S&P 500.
*   The expected return is promising for long-term investors.
*   The price change of 0.6 suggests the price have some volatility.

**4. Recent News & Significant Events**

*   **2025-05-30:** Major business developments, regulatory changes, or market events.
*   **2025-05-28:** Analyst discussions on recent performance and outlook in the context of industry trends and global economic factors.
*   **2025-05-29:** Stock showing notable volatility.
*   **2025-05-27:** Market experts highlighting risks and opportunities.

**Analysis:** The news indicates recent activity and volatility in ISRG's stock, requiring further investigation to understand the specific drivers.

**5. Recent Earnings Analysis**

| 날짜       | EPS  | 매출       |
|------------|------|------------|
| 2025-04-23 | 1.95 | 2.25 B$    |
| 2024-10-18 | 1.59 | 2.04 B$    |
| 2024-07-19 | 1.48 | 2.01 B$    |
| 2024-04-19 | 1.54 | 1.89 B$    |
| 2025-04-23 | 1.54 | 1.89 B$    |

**Analysis:**

*   EPS and revenue generally show an upward trend.
*   The most recent EPS data shows the highest EPS figure in the data set.
*   The most recent revenue data shows the highest Revenue figure in the data set.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-03-31   | $2.25B    | 64.69%        |
| 2024-12-31   | $2.41B    | 68.04%        |
| 2024-09-30   | $2.04B    | 67.41%        |
| 2024-06-30   | $2.01B    | 68.30%        |
| 2024-03-31   | $1.89B    | 65.87%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE   |
|--------------|-----------|-------|
| 2025-03-31   | $17.11B   | 4.08% |
| 2024-12-31   | $16.43B   | 4.17% |
| 2024-09-30   | $15.58B   | 3.63% |
| 2024-06-30   | $14.71B   | 3.58% |
| 2024-03-31   | $13.96B   | 3.90% |

**Analysis:**

*   **Revenue:** Generally increasing, indicating strong demand for Intuitive Surgical's products and services.
*   **Profit Margin:** Relatively stable and high, suggesting efficient cost management.
*   **Equity:** Steadily growing, showing healthy capital accumulation.
*   **ROE:** Fluctuates, but generally remains at a good level.

**7. Summary Analysis**

Overall, Intuitive Surgical (ISRG) exhibits a strong long-term track record, with significant outperformance compared to the S&P 500. Recent technical indicators suggest caution in the short term due to approaching overbought conditions and a recent weakening relative to the market.  However, strong revenue and profit margin trends, along with a promising long-term expected return, support a positive outlook for long-term investors.  The recent news indicating volatility necessitates further investigation to assess potential risks and opportunities. Recent EPS and Revenue data show the highest number in the data set.
